ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Molecular Characterization of Progressive Fibrosis in the Liver by Single-Nuclei RNA Sequencing

T. Rousselle1, J. McDaniels1, A. Shetty1, E. Bardhi1, D. Polsky1, E. Williams1, D. Maluf2, V. Mas1

1Surgical Sciences, University of Maryland Baltimore, Baltimore, MD, 2Transplantation Program, University of Maryland Medical Center, Baltimore, MD

Meeting: 2022 American Transplant Congress

Abstract number: 1431

Keywords: Fibrosis, Liver cirrhosis

Topic: Clinical Science » Liver » 53 - Liver: Cirrhosis - Portal Hypertension and Other Complications

Session Information

Session Name: Liver: Cirrhosis - Portal Hypertension and Other Complications

Session Type: Poster Abstract

Date: Monday, June 6, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: The prevalence of obesity is negatively affecting the availability of livers for transplantation. Non-alcoholic fatty liver disease (NAFLD) is associated with an increase in inflammatory processes which potentially contribute to the exacerbation of fibrosis and development of cirrhosis. Hereby, we assess the use of single-nucleus RNA sequencing to identify the molecular mechanisms by which NAFLD progresses towards fibrosis at the single-cell resolution to derive therapies with potential to rescue organs from being discarded.

*Methods: Single nuclei isolated from flash-frozen samples included normal, NAFLD, non-alcoholic steatohepatitis (NASH), and cirrhosis. Cell types were analyzed for differentially expressed genes, which were further characterized by the predictive subcellular localization of the associated translated protein. Gene sets predicted to localize to the nucleus, cytosol, and mitochondria were individually explored for KEGG/GO-term enrichment and pathway analysis.

*Results: Four hepatocyte (HEP) clusters and two hepatoblast (HpB) clusters were identified. HEP-1 and HpB-1 were found to be expressed almost exclusively in NAFLD. Gene clusters associated with mitochondria-localized gene products within HpB-1 were enriched for GO-terms specific to fatty acid oxidation and an upregulation of reducing power. In contrast, HEP-1 was found to be enriched for oxidative stress localized to the cytosol and have an increased reliance on amino acid metabolism, specifically the catabolism of branched chain amino acids by the upregulated activity of MCCC1, DBT, and HIBCH. Taken together, these findings would suggest a progression of metabolic dysfunction from HpB-1 to HEP-1. In addition, these two cell types were also found to have a significantly higher concentration of genes associated with ECM production. Further study is needed to determine the cellular pathways by which these cell types progress to NASH and further to Cirrhosis.

*Conclusions: In this study, we identify two cell types exclusively found in NAFLD which show an upregulated response to oxidative stress and fibrogenic mechanisms in light of progressive metabolic dysregulation. With continued progression, on-set of fibrosis lends to the eradication of hepatocytes and replacement of epithelial cells with fibrotic cells, thereby highlighting the cellular shift from NAFLD to Cirrhosis.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Rousselle T, McDaniels J, Shetty A, Bardhi E, Polsky D, Williams E, Maluf D, Mas V. Molecular Characterization of Progressive Fibrosis in the Liver by Single-Nuclei RNA Sequencing [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/molecular-characterization-of-progressive-fibrosis-in-the-liver-by-single-nuclei-rna-sequencing/. Accessed May 8, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences